Research Project
Grant-in-Aid for Young Scientists (B)
To establish a testing algorithm for EGFR mutation status in NSCLC patients, we utilized PNA-LNA PCR clamp assay and immunostaining. In the 133 samples, positive, negative and equivocal results for EGFR mutation-specific antibodies were observed in 37 patients (27.8%), 85 patients (63.9%) and 11 patients (8.3%), respectively. Thirty-seven patients showed positive EGFR expression by immunostaining, and 35 (94.6%) of these also tested positive in the DNA-based assay. Of 85 EGFR-negative patients by immunostaining, 77 (90.6%) also tested negative in the DNA-based assay. In NSCLC patients treated with EGFR-TKIs, the progression-free survival after the start of EGFR-TKIs treatment was significantly longer in patients with EGFR positive expression than in those with equivocal and negative expression (P = 0.002). Our results suggest immunostaining for EGFR mutation-specific antibodies are a new test for EGFR-TKI inhibition and could be a useful indicator with regard to patient management.
All 2013 2012 2011
All Journal Article (26 results) (of which Peer Reviewed: 26 results) Presentation (31 results)
Cancer Res
Volume: 73 Issue: 20 Pages: 6243-6253
10.1158/0008-5472.can-12-4502
PLoS ONE
Volume: 5 Issue: 8 Pages: e71356-e71356
10.1371/journal.pone.0071356
Med Oncol
Volume: 30巻 Issue: 1 Pages: 349-349
10.1007/s12032-012-0349-y
The Journal of the Japanese Society of Clinical Cytology
Volume: 52 Issue: 5 Pages: 473-477
10.5795/jjscc.52.473
10031191694
Molecular and Clinical Oncology
Volume: 1 Issue: 4 Pages: 625-632
10.3892/mco.2013.107
International journal of clinical oncology
Volume: 18 Issue: 2 Pages: 293-304
10.1007/s10147-012-0378-8
10031176269
Molecular cancer therapeutics
Volume: 12 Issue: 5 Pages: 737-746
10.1158/1535-7163.mct-12-1125
Nuclear medicine communications
Volume: 34 Issue: 6 Pages: 562-570
10.1097/mnm.0b013e328360d945
Anticancer research
Volume: 33 Pages: 2941-2947
J Biol Chem
Volume: 288 Issue: 35 Pages: 25025-25037
10.1074/jbc.m113.472068
Pathology international
Volume: 63 Issue: 9 Pages: 463-368
10.1111/pin.12087
Cancer Sci.
Volume: 104 Issue: 10 Pages: 1285-1294
10.1111/cas.12226
Experimental and therapeutic medicine
Volume: 6 Issue: 5 Pages: 1089-1095
10.3892/etm.2013.1289
Oncology Reports
Volume: 30 Issue: 5 Pages: 2035-2041
10.3892/or.2013.2720
Lung Cancer
Volume: 78巻 Issue: 1 Pages: 39-44
10.1016/j.lungcan.2012.07.002
Volume: 51 Issue: 2 Pages: 120-124
10.5795/jjscc.51.120
130004513125
Oncol Lett
Volume: 4巻 Issue: 3 Pages: 477-482
10.3892/ol.2012.753
Eur J Radiol.
Volume: 81 Issue: 12 Pages: 4179-84
10.1016/j.ejrad.2012.07.009
PLoS One
Volume: 7巻 Issue: 7 Pages: e41017-e41017
10.1371/journal.pone.0041017
Journal of Thoracic Oncology
Volume: (In press) Issue: 5 Pages: 779-789
10.1097/jto.0b013e31824c92b4
Cancer Sci
Volume: 103(4) Issue: 4 Pages: 638-644
10.1111/j.1349-7006.2012.02202.x
Lung Cancer.
Volume: 78 Pages: 39-44
Volume: 6 Issue: 1 Pages: 122-127
10.1097/jto.0b013e31822eeba2
Volume: 74巻 Issue: 1 Pages: 35-40
10.1016/j.lungcan.2011.02.002
Cancer Cytopathol
Volume: 119巻 Issue: 5 Pages: 335-340
10.1002/cncy.20162
Volume: 73 Pages: 35-40